SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-149693
Filing Date
2014-04-21
Accepted
2014-04-21 07:04:23
Documents
3
Period of Report
2014-04-21
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d715447d8k.htm 8-K 13892
2 EX-99.1 d715447dex991.htm EX-99.1 24814
3 GRAPHIC g715447g73f47.jpg GRAPHIC 10666
  Complete submission text file 0001193125-14-149693.txt   54937
Mailing Address 215 FIRST STREET SUITE 7 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 7 CAMBRIDGE MA 02142 857-242-3700
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14895 | Film No.: 14772777
SIC: 2834 Pharmaceutical Preparations